Caribou Biosciences (CRBU) vs Genenta Science S.p.A. (SAEN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Caribou Biosciences is the larger company by market cap ($30.7 million vs $24.5 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRBU | SAEN |
|---|---|---|
| Share price | $0.2843 | $0.5074 |
| Market cap | $30.71M | $24.47M |
| 1-day change | -8.44% | -9.39% |
| YTD return | -82.12% | — |
| 1-year return | -83.75% | — |
| 5-year return | -98.39% | — |
| EPS (TTM) | $-1.03 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $11.16M | — |
| Revenue growth (YoY) | +11.66% | — |
| Net income (latest FY) | $-148.13M | — |
| Operating margin | -1329.37% | — |
| Net margin | -1327.40% | — |
| 52-week high | $2.49 | $2.58 |
| 52-week low | $0.2819 | $0.50 |
| Distance from 52-week high | -88.58% | -80.33% |
| Analyst consensus | buy | — |
| Avg. price target upside | +1922.51% | — |
| Average volume | 2.87M | 85.01K |
| Shares outstanding | 108.04M | 48.22M |
| Employees | 97 | 9 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Caribou Biosciences
CRBU stock →Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 97 employees
About Genenta Science S.p.A.
SAEN stock →Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 9 employees
CRBU vs SAEN FAQ
Which is bigger, Caribou Biosciences or Genenta Science S.p.A.?
Caribou Biosciences (CRBU) is larger, with a market capitalization of $30.71M compared with $24.47M for Genenta Science S.p.A. (SAEN).
Are Caribou Biosciences and Genenta Science S.p.A. in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.